Skip to main contentAbout USAID Locations Our Work Public Affairs Careers Business / Policy
USAID: From The American People - Link to USAID Home Page Frontlines USAID's 50th Anniversary

  Press Home »
Press Releases »
Mission Press Releases »
New Developments »
Fact Sheets »
Media Advisories »
Speeches and Test »
Development Calendar »
Evidence Summits »
Reports to Congress »
Photo Gallery »
FrontLines »
Contact
USAID
»
 
 
Inside this Issue
Indonesia
USAID Information: External Links:
Malaria
Search



Indonesia Fights Drug-resistant Tuberculosis Strains

FrontLines - March 2010

By Roman Woronowycz


JAKARTA —Rohmin*, 41, drives a taxi in Jakarta, a bustling, overcrowded megapolis. Tuberculosis is common and a cab is an easy place to pick it up.

So when Rohmin began coughing up blood more than a year ago, he sought medical help and was told that he had TB. With a wife and four children to support, Rohmin had little time for treatment.

Photo by Roman Woronowycz, USAID
Dr. Lia Gardenia Partakusuma (left), Persahabatan Hospital’s director of general affairs, human resources, and education; and Dr. Erlina Burhan, chief pulmonologist, discuss the hospital’s MDR -TB program.

Twice he took medication and twice he quit after he felt better. The third time the disease returned with a vengeance as multi-drug resistant TB (MDRTB): difficult to detect and difficult to cure.

Today Rohmin swallows 28 tablets daily, including vitamins. He will take them for the next two years with little choice. This time he either completes treatment or faces death.

Dr. Erlina Burhan, chief pulmonologist at Persahabatan Hospital in Jakarta where Rohmin is an inpatient, believes that he will complete treatment. “He’s committed,” she said.

She said that Rohmin is monitored to ensure he adheres to an internationally recognized system for treating tuberculosis known as Programmatic Management of Drug Resistant TB (PMDT). The treatment is more intensive than the treatment for standard TB, known as Directly Observed Treatment, Short course (DOTS).

“Most MDR patients have a previous history of TB and have either taken medication and stopped, or received inadequate doses or counseling,” Burhan said.

Indonesia is reducing its rate of TB, which has fallen from 115 cases per 100,000 people in 2002, when USAID began supporting the fight against TB, to 100 cases per 100,000 in 2008. Currently, 91 percent of those in treatment have a successful outcome.

Yet, even as TB rates begin to slow, the resistant TB is becoming more prevalent.

Each year, World Tuberculosis Day, a worldwide call to combat the disease, is observed on March 24. USAID is working among global efforts to halve TB rates and deaths by 2015.

USAID has provided $18 million since 2002 to Indonesia’s Ministry of Health for programs through 2010 and is now increasing its focus on drug resistant TB. A new pilot project will identify and treat 100 MDR-TB patients in Jakarta and Surabaya.

Rohmin is among the first 10 patients in treatment.

Dr. Sri Prihatini, a World Health Organization TB consultant, said that the key to success is a referral and monitoring system that connects local doctors and health centers with hospitals in a communication network that ensures patients remain in treatment.

A good program will reduce default cases, preventing new drug resistant TB cases. “TB treatments work better at the local health centers because the doctors and nurses know and track their patients,” said Prihatini. “We need for hospitals to notify local officials when one of their patients becomes a no show.”

The pilot projects in Surabaya and Jakarta ensure that local government health centers and hospitals understand PMDT and how to implement it. Prihatini said that before the pilot projects are rolled out, it will be crucial to train medical professionals in the surrounding areas in the new system. It will be equally important to have enough labs certified in MDR-TB testing.

She believes that adequate preparation is the key to success in fighting MDR-TB. “But it is also dependent on commitment by the local clinics, the hospitals, and the government,” she said. And by the patient, too, she added.

*Many Indonesians do not use a surname.

 


FrontLines is published by the Bureau for Legislative and Public Affairs
U.S. Agency for International Development

To have FrontLines delivered to you via postal mail, please subscribe.

Material should be submitted by mail to Editor, FrontLines, USAID,
RRB, Suite 6.10, Washington, DC 20523-6100;
by FAX to 202-216-3035; or by e-mail to frontlines@usaid.gov

To view PDF files, download
the Adobe Acrobat Reader.

Back to Top ^

 

About USAID

Our Work

Locations

Public Affairs

Careers

Business/Policy

 Digg this page : Share this page on StumbleUpon : Post This Page to Del.icio.us : Save this page to Reddit : Save this page to Yahoo MyWeb : Share this page on Facebook : Save this page to Newsvine : Save this page to Google Bookmarks : Save this page to Mixx : Save this page to Technorati : USAID RSS Feeds Star